DEERFIELD, Ill.–(BUSINESS WIRE)–Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth and leave solutions, today announced a new health reimbursement account (HRA) that helps employers offer financial support to their employees for eligible GLP-1 medications, while enabling more control over program costs and design.The Alight GLP-1 HRA gives employers another way to support employees as they incorporate GLP-1 medications into their broader health and benefits

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.